Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
Purpose. The aim of this study was to assess the effect of intravitreal injections (IVI) of ranibizumab and aflibercept on the choroidal thickness (CT) in patients with treatment-naive diabetic macular edema (DME) before and after monthly IVI. Patients and Methods. Prospective monocenter study. Incl...
Saved in:
| Main Authors: | Valérie Sarda, Pauline Eymard, Linda Hrarat, Franck Fajnkuchen, Audrey Giocanti-Aurégan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/5708354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of aflibercept in treating bevacizumab resistant macular edema
by: Hussain Khudair Yassin
Published: (2024-12-01) -
Relationship between diabetic macular edema and choroidal layer thickness.
by: Hiroaki Endo, et al.
Published: (2020-01-01) -
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01) -
Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-03-01) -
Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)